BBIO
Price
$79.54Alerts
Change
+$0.87 (+1.11%)
Updated
Nov 11 closing price
Capitalization
14.52B
105 days until earnings call
Intraday BUY SELL Signals
VKTX
Price
$28.44Alerts
Change
-$0.22 (-0.77%)
Updated
Nov 11 closing price
Capitalization
3.34B
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BBIO vs VKTX

BBIO vs VKTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BBIO vs. VKTX commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a StrongBuy and VKTX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BBIO with price predictions
Nov 11, 2026

Aroon Indicator for BBIO shows an upward move is likely

BBIO's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 208 similar instances where the Aroon Indicator showed a similar pattern. In 188 of the 208 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BBIO as a result. In 76 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

BBIO moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BBIO crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.

Following a +2.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBIO advanced for three days, in 247 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for BBIO moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

BBIO broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-5.774) is normal, around the industry mean (3.498). P/E Ratio (-20.868) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (18.587) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. BBIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for VKTX with price predictions
Nov 11, 2026

VKTX's RSI Oscillator climbs out of oversold territory

The RSI Indicator for VKTX moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In 32 of the 37 cases the stock moved higher. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on VKTX as a result. In 74 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for VKTX just turned positive on October 29, 2026. Looking at past instances where VKTX's MACD turned positive, the stock continued to rise in 43 of 50 cases over the following month. The odds of a continued upward trend are 86%.

Following a +12.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where VKTX advanced for three days, in 236 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for VKTX moved below the 200-day moving average on October 07, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VKTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

VKTX broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VKTX entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. VKTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.184) is normal, around the industry mean (3.498). P/E Ratio (-5.747) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VKTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
BBIO vs VKTX: Fundamental Ratings
BBIO
VKTX
OUTLOOK RATING
1..100
4410
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
6078
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4161
P/E GROWTH RATING
1..100
3316
SEASONALITY SCORE
1..100
5026

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BBIO's Valuation (7) in the null industry is somewhat better than the same rating for VKTX (71) in the Biotechnology industry. This means that BBIO’s stock grew somewhat faster than VKTX’s over the last 12 months.

BBIO's Profit vs Risk Rating (60) in the null industry is in the same range as VKTX (78) in the Biotechnology industry. This means that BBIO’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's SMR Rating (98) in the Biotechnology industry is in the same range as BBIO (100) in the null industry. This means that VKTX’s stock grew similarly to BBIO’s over the last 12 months.

BBIO's Price Growth Rating (41) in the null industry is in the same range as VKTX (61) in the Biotechnology industry. This means that BBIO’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's P/E Growth Rating (16) in the Biotechnology industry is in the same range as BBIO (33) in the null industry. This means that VKTX’s stock grew similarly to BBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BBIOVKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BBIO: $79.54 vs. VKTX: $28.44)
Brand notoriety: BBIO and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 60% vs. VKTX: 44%
Market capitalization -- BBIO: $14.52B vs. VKTX: $3.34B
BBIO [@Biotechnology] is valued at $14.52B. VKTX’s [@Biotechnology] market capitalization is $3.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 2 FA rating(s) are green while VKTX’s FA Score has 1 green FA rating(s).

  • BBIO’s FA Score: 2 green, 3 red.
  • VKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, BBIO is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 5 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • BBIO’s TA Score: 5 bullish, 4 bearish.
  • VKTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BBIO is a better buy in the short-term than VKTX.

Price Growth

BBIO (@Biotechnology) experienced а +2.12% price change this week, while VKTX (@Biotechnology) price change was +1.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.

Reported Earning Dates

BBIO is expected to report earnings on Feb 25, 2027.

VKTX is expected to report earnings on Feb 10, 2027.

Industries' Descriptions

@Biotechnology (-0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
+1.11%
AXON - BBIO
44%
Loosely correlated
+4.26%
ARRY - BBIO
43%
Loosely correlated
+9.94%
PMN - BBIO
43%
Loosely correlated
-5.53%
VKTX - BBIO
43%
Loosely correlated
-0.77%
CYTK - BBIO
41%
Loosely correlated
+4.18%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with SANA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-0.77%
SANA - VKTX
48%
Loosely correlated
-5.76%
FDMT - VKTX
47%
Loosely correlated
+4.25%
KYTX - VKTX
46%
Loosely correlated
+0.79%
VIR - VKTX
45%
Loosely correlated
-0.15%
JAGX - VKTX
45%
Loosely correlated
+10.46%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CHAI0.170.01
+7.44%
Core AI Holdings Inc
ROBO74.081.49
+2.05%
ROBO Global Robotics & Automation Index ETF (ROBO)
MJ22.810.03
+0.11%
Amplify Alternative Harvest ETF (MJ)
MART42.81N/A
N/A
AllianzIM U.S. Equity Buffer10 Mar ETF (MART)
TAXI51.24-0.29
-0.56%
Northern Trust Intermediate Tax-Exempt Bond ETF (TAXI)